14 results on '"Baldari S."'
Search Results
2. B19 - Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study
3. B7 - Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)
4. B8 - Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)
5. 1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study
6. Use of sulesomab in the diagnosis of brucellar spondylitis
7. OD154 - Internal dosimetry Monte Carlo study of TARE treatments: a comparison between GATE and GAMOS focused on lung dosimetry and background correction
8. PCN168 Lutetium (177LU) Oxodotreotide Versus Standard of Care in Adult Patients with Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): A Cost-Consequences Analysis from an Italian Hospital Perspective
9. 313. Estimation of the radiation absorbed dose to the choroid plexuses in 68Ga-NODAGA-RGD PET
10. 93. Estimation of doses to the extremities during manipulation of radiopharmaceuticals in nuclear medicine: A Monte Carlo calculation approach in realistic geometric lay-outs
11. 1331P - Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)
12. 826P - Use of bone health agents (BHAs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) after abiraterone (Abi): An interim review of REASSURE
13. PT092 - REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe
14. C19 - Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.